| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.06 | 0.3 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |